Improving Stroke Discharge Outcomes: Marian LaMonte, MD, MSN, FAAN


The chief of neurology at Ascension Saint Agnes discussed the interventions her team implemented to improve patient-specific stroke discharge instructions.

“One of the things that stroke programs could do to improve compliance is work more closely with their IT and Information Services people. When they see that their work makes a difference, clinically, they're happy and it makes them feel as though they're really contributing to the health of the patient.”

Implementing simple educational and decision support interventions improved physician compliance with providing patient-specific stroke discharge instructions (DCI) in a recent study conducted at Ascension Saint Agnes Hospital. These findings were presented virtually by Marian LaMonte, MD, MSN, FAAN, chief of neurology, Ascension Saint Agnes, at the 2021 American Academy of Neurology (AAN) Annual Meeting, April 17-22

LaMonte and colleagues implemented an intervention bundle in the hospital’s electronic medical records system that consisted of simple educational activities, reminders, and decision support tools. This intervention increased compliance in providing stroke specific DCI by 38.6%, from 51.9% pre-intervention to 90.5% within 4 months. Improvements in compliance were seen in the teaching service from 60.0% to 90.5% and non-teaching service from 25.0% to 87.5%. 

NeurologyLive spoke to LaMonte to learn more about the changes her team implemented in their electronic medical record system during the study. She also discussed how care centers can work to improve provision of patient-specific stroke DCI. 

For more coverage of AAN 2021, click here.

Asfaw M, LaMonte M. Improving stroke patient discharge instructions use. Presented at 2021 American Academy of Neurology Annual Meeting; April 17-22. Abstract P5 119
Related Videos
Michael Levy, MD, PhD
Michael Kaplitt, MD, PhD
Michael Kaplitt, MD, PhD
video 4 - "Amyloid Cascade Hypothesis of Alzheimer’s Disease"
Video 3 - "Amyloid Precursor Protein and Amyloid Beta Species in Alzheimer’s Disease"
Svetlana Blitshteyn, MD, FAAN, director and founder of Dysautonomia Clinic
© 2024 MJH Life Sciences

All rights reserved.